NCT01010685

Brief Summary

The benefits of laparoscopic ("minimally invasive" or "keyhole") surgery for gallbladder removal (cholecystectomy) over open surgical procedures in terms of significant reductions in pain, scarring and recovery time are well accepted. In a conventional laparoscopic cholecystectomy however, the excised gallbladder still has to be extracted through the abdominal wall skin via a laparoscopic port site using an incision of 10mm or greater. Despite being much smaller than that required for open surgery, this incision is painful, leaves a scar and can result in a port site hernia to follow requiring further surgery to repair it. Recent attempts to further reduce the invasiveness of the surgical procedure have suggested performing the operation via an endoscope passed through the mouth and through an incision in the stomach wall - so called Natural Orifice Translumenal Endoscopic Surgery (NOTES). Unlike a skin incision, an incision in the wall of the stomach (gastrotomy) should give no pain, visible scar or herniation risk yet still allow access to the peritoneal cavity for surgical procedures such as cholecystectomy. Against this, it has the potential risks of contamination and leakage of gastric contents into the peritoneal cavity. Whilst the limitations of present technology make it very difficult to perform an entire cholecystectomy through the stomach wall in patients, endoscopic methods for closing a gastrotomy are available that are approved for use in patients (CE marked) and it is hypothesised that removing the excised gallbladder through the stomach in this way would avoid the problems of extracting it through the abdominal wall described above. Data are required to determine whether the extraction of the gallbladder via a gastrotomy rather than through the skin is safe, producing smaller scars and a better cosmetic result. A secondary endpoint would be to assess possible reductions in pain and recovery from this less invasive approach.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 7, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 10, 2009

Completed
21 days until next milestone

Study Start

First participant enrolled

December 1, 2009

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

February 5, 2014

Status Verified

February 1, 2014

Enrollment Period

4.2 years

First QC Date

November 7, 2009

Last Update Submit

February 4, 2014

Conditions

Keywords

Natural Orifice Transluminal Endoscopic Surgery (NOTES)Transgastric surgerySurgical Procedures, Minimally Invasive

Outcome Measures

Primary Outcomes (1)

  • This is a pilot study aimed at examining the outcomes of gallbladder recovery through a gastrotomy, concentrating on safety. The main outcome is presence of surgical complications.

    6 months

Secondary Outcomes (1)

  • Secondary outcomes include pain levels and cosmetic satisfaction

    6 months

Interventions

The gallbladder is dissected as for a standard laparoscopic cholecystectomy but is then recovered via a hole in the stomach created and closed endoscopically rather than through the skin as in the standard fashion

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Fit patients, avoiding extremes of age, with uncomplicated gallstone disease requiring elective laparoscopic cholecystectomy.

You may not qualify if:

  • Direct healthcare team deny permission to approach patient for trial.
  • Patient request / preference.
  • Age (\< 21 or \> 65 yrs old).
  • Co-morbidity (ASA level 3 or above).
  • BMI \> 32.
  • Complicated gallstone disease (eg bile duct stones/ERCP/pancreatitis).
  • Gallstones ≥ 18 mm size (too large to recover via oesophagus).
  • Pregnancy.
  • Previous gastric or upper abdominal surgery (alterations in gastric anatomy or adhesions preventing safe gastrotomy).
  • Emergency procedure.
  • Planned other operation during cholecystectomy.
  • Inability to consent or psychiatric or addiction problems relevant to surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Colchester General Hospital

Colchester, Essex, CO4 5JL, United Kingdom

Location

MeSH Terms

Conditions

Gallstones

Condition Hierarchy (Ancestors)

CholelithiasisBiliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Ralph Austin, MS, FRCS

    Colchester General Hospital

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant laparoscopic surgeon

Study Record Dates

First Submitted

November 7, 2009

First Posted

November 10, 2009

Study Start

December 1, 2009

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

February 5, 2014

Record last verified: 2014-02

Locations